{
  "page_summary": "This page discusses the process and significance of pathologic assessment following breast cancer tissue removal, including macroscopic and microscopic examinations, immunohistochemistry for estrogen and progesterone receptors (ER, PR), HER2 status via IHC or ISH, and other tumor characterizations such as differentiation grading. The content explains how these pathological analyses provide important information on cancer type and aggressiveness, but does not define concrete clinical trial endpoints.",
  "endpoint_candidates": []
}